 |
 |
|
|
|  PubMed
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 February 1995 | Volume 122 Issue 3 | Pages 210-217
Objective: To describe the diagnostic difficulties, response to therapy, and clinical features of lymphomatoid papulosis and the cumulative frequency of transformation to lymphoma.
Design: Case series.
Setting: University hospitals.
Methods: The records of 21 patients with lymphomatoid papulosis who were seen from 1986 to 1993 were retrieved from the archives of two institutions. The entry criteria for the study were lymphomatoid papulosis misdiagnosed at the time of original presentation or lymphomatoid papulosis that later developed into lymphoma.
Results: When lymphomatoid papulosis tissues are pathologically examined, they are frequently confused with lymphoma, melanoma, or carcinoma. Eight of the 19 patients whose condition was misdiagnosed as malignant received either chemotherapy or radiotherapy. Although lymphomatoid papulosis responded to cytotoxic chemotherapy, the remissions were transient and promptly recurred after or during treatment. However, all five cases that became malignant responded to chemotherapy and have not recurred. Five of 21 patients (24%) developed lymphoma, but the cumulative risk for transformation after 15 years was 80%.
Conclusions: Lymphomatoid papulosis can only be diagnosed accurately through a careful history in which the characteristic waxing and waning of the skin lesions is identified and through proper communication between clinicians and pathologists. Patients with lymphomatoid papulosis have an increased risk for developing lymphoma that is much higher than the 15% to 20% quoted in the literature. Patients who develop lymphoma respond well to cytotoxic chemotherapy and can be cured with appropriate therapy. Internists and oncologists need to be aware of lymphomatoid papulosis and its characteristic clinical features so that this disorder is accurately diagnosed and so that unnecessary and potentially hazardous treatment is avoided.
Author and Article Information
From The University of Texas M.D. Anderson Cancer Center, Houston, Texas; and the University of Nebraska Medical Center, Omaha, Nebraska.
CLINICAL REVIEW
Lymphomatoid Papulosis: A T-Cell Dyscrasia with a Propensity To Transform into Malignant Lymphoma
Requests for Reprints: Fernando Cabanillas, MD, Department of Hematology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard (Box 068), Houston, TX 77030.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Gruber, N. T. Sepp, P. O. Fritsch, and M. Schmuth Prognosis of Lymphomatoid Papulosis Oncologist, September 1, 2006; 11(8): 955 - 957. [Full Text] [PDF]
|
|
|
|
|
|
E. Jacobsen Anaplastic Large-Cell Lymphoma, T-/Null-Cell Type Oncologist, July 1, 2006; 11(7): 831 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Franchina, M. E. Kadin, and L. J. Abraham Polymorphism of the CD30 Promoter Microsatellite Repressive Element Is Associated with Development of Primary Cutaneous Lymphoproliferative Disorders Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1322 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Brown and A. T. Skarin Clinical Mimics of Lymphoma Oncologist, July 1, 2004; 9(4): 406 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nijsten, C. Curiel-Lewandrowski, and M. E. Kadin Lymphomatoid Papulosis in Children: A Retrospective Cohort Study of 35 Cases Arch Dermatol, March 1, 2004; 140(3): 306 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Younes and M. E. Kadin Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy J. Clin. Oncol., September 15, 2003; 21(18): 3526 - 3534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kempf, M. E. Kadin, A. M. Dvorak, C. C. Lord, G. Burg, N. L. Letvin, and I. J. Koralnik Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin Carcinogenesis, February 1, 2003; 24(2): 301 - 306. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Visco, L. J. Medeiros, D. Jones, T. Smith, M. A. Rodriguez, P. McLaughlin, J. Romaguera, F. Cabanillas, and A. H. Sarris Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement Ann. Onc., August 1, 2002; 13(8): 1290 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Rozycki and M. D. P. Davis Recurrent Pruritic Papules in a 74-Year-Old Man Arch Dermatol, October 1, 2001; 137(10): 1367 - 1372. [Full Text] [PDF]
|
|
|
|
|
|
A. H. Sarris, I. Braunschweig, L. J. Medeiros, M. Duvic, C. S. Ha, M. A. Rodriguez, F. B. Hagemeister, P. McLaughlin, J. Romaguera, J. Cox, et al. Primary Cutaneous Non-Hodgkin's Lymphoma of Ann Arbor Stage I: Preferential Cutaneous Relapses but High Cure Rate With Doxorubicin-Based Therapy J. Clin. Oncol., January 15, 2001; 19(2): 398 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Siegel, T. Pandolfino, J. Guitart, S. Rosen, and T. M. Kuzel Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts J. Clin. Oncol., August 15, 2000; 18(15): 2908 - 2925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Bekkenk, F. A. M. J. Geelen, P. C. v. V. Vader, F. Heule, M.-L. Geerts, W. A. van Vloten, C. J. L. M. Meijer, and R. Willemze Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment Blood, June 15, 2000; 95(12): 3653 - 3661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Lymphomatoid Papulosis Has a High Risk of Transforming into Lymphoma Journal Watch Dermatology, April 1, 1995; 1995(401): 11 - 11. [Full Text]
|
|
